New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
09:18 EDTGALE, YGE, NUAN, QIWI, FST, MDT, EXPE, PGEM, ANFI, HIMX, DSWOn The Fly: Pre-market Movers
HIGHER: Amira Nature Foods (ANFI), up 30% after Q4 results top expectations... DSW (DSW), up 2.6% after upgraded at Goldman... Yingli Green Energy (YGE), up 3.4% after reaffirming its FY14 PVmodule shipment target... Nuance (NUAN), up 3% after WSJ reported yesterday that the company is looking into potential sale, Oppenheimer estimates that Nuance could be sold for $25-$30... Medtronic (MDT), up 2.8% after upgrades at Morgan Stanley, Credit Suisse, and RBC Capital... Forest Oil (FST), up 15% after Sabine Oil & Gas denies $850M bridge financing facility was pulled... Galena (GALE), up 5% after completing enrollment in GALE-301 Phase 2a trial... Expedia (EXPE), up 2.6% following upgrade at Susquehanna. LOWER: Ply Gem (PGEM), down 5.8% after downgraded at Goldman... Himax (HIMX), down 4.4% after downgraded at UBS... QIWI (QIWI), down 3.6% after 7.973M share Secondary priced at $40.00.
News For DSW;EXPE;NUAN;HIMX;MDT;YGE;ANFI;FST;GALE;PGEM;QIWI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 25, 2015
07:02 EDTDSWDSW reports Q2 EPS 42c, consensus 42c
Subscribe for More Information
August 24, 2015
18:55 EDTNUANOn The Fly: After Hours Movers
Subscribe for More Information
16:46 EDTYGEPresident Obama announces new renewable energy commitments
Subscribe for More Information
15:09 EDTDSWNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Best Buy (BBY), consensus 34c... Toll Brothers (TOL), consensus 49c... Valspar (VAL), consensus $1.26... DSW (DSW), consensus 42c... Children's Place (PLCE), consensus (33c).
11:09 EDTYGEGoldman says SolarCity attractive after sharp pullback
SolarCity (SCTY) shares are climbing in the down market after Goldman Sachs contended in a note to investors today that the stock is attractive following its recent sharp retreat, The company probably won't be affected by issues that are causing investors to worry about the solar sector, the firm believes. WHAT'S NEW: Noting that SolarCity's stock had tumbled 27% in the last month before today's open, Goldman Sachs analyst Brian Lee wrote that the shares are being dragged down by worries about financing and cost of capital that are affecting the entire solar sector. However, he contended that these issues are having only a "limited" impact on SolarCity. On August 13, the company successfully sold asset-backed securities and it said that more such sales are likely to occur in the near-term, Lee noted. Meanwhile, SolarCity isn't being affected by the cost of capital increases that other solar companies are experiencing, the analyst reported. Before today's open, the stock was near a two year low, even though SolarCity's fundamentals are still "strong," Lee believes. Additionally, the largest U.S. solar trade show, which is expected to begin on September 14, could boost solar stocks, as it has historically been a catalyst for the sector, the analyst stated. SolarCity may provide guidance about the outlook for its Silevo solar panel manufacturing subsidiary in the second half of 2015, and the guidance could boost the stock, Lee believes. The risk/reward ratio of SolarCity's stock is positive, according to the analyst, who has a Conviction List Buy and $85 price target on the shares. OTHERS TO WATCH: Other publicly traded companies in the solar space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunEdison (SUNE), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE). PRICE ACTION: In late morning trading, SolarCity advanced 5.3% to $43.18.
07:07 EDTGALEIDMC recommends reduction of cardiac toxicity monitoring in Galena NeuVax trial
Galena Biopharma announced that the Independent Data Monitoring Committee, or IDMC, has recommended to the company that it can reduce the cardiac toxicity monitoring for patients in its NeuVax Phase 3 Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment, or PRESENT, clinical trial. The trial is being run under a Special Protocol Assessment, or SPA, approved by the FDA. Following its most recent IDMC meeting in June, the IDMC recommended routine cardiac monitoring could be reduced in the PRESENT trial and that such a reduction is justified and consistent with the pre-specified Cardiac Toxicity Monitoring Stopping Rules defined in the study protocol. The IDMC concluded that cardiac toxicity monitoring by echocardiogram, or ECHO, or multiple-gated acquisition, or MUGA, scans could be reduced. The IDMC had no other suggestions and recommended the trial continue as planned.
August 21, 2015
10:02 EDTYGEOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:59 EDTANFIAmira Nature Foods rejects 'misleading' claims made by Prescience Point
Subscribe for More Information
08:18 EDTYGEYingli Green Energy initiated with a Sell at Axiom
Subscribe for More Information
06:56 EDTYGESolar companies spending $1B in Texas projects, WSJ says
Subscribe for More Information
August 20, 2015
09:30 EDTDSWDSW Q2 revenue tracking below consensus, says ITG Research
Subscribe for More Information
August 19, 2015
18:34 EDTANFIOn The Fly: After Hours Movers
Subscribe for More Information
17:54 EDTANFIAmira Nature Foods terminates Deloitte, appoints ASA as accounting firm
Amira Nature Foods disclosed in a regulatory filing that on August 19, the Audit Committee of Amira Nature Foods appointed ASA & Associates as the company's independent registered public accounting firm for the year ended March 31, effective immediately, and ASA & Associates accepted the engagement on August 19. Simultaneously with the engagement of ASA & Associates, the company terminated Deloitte Haskins & Sells as its independent registered public accounting firm. For the years ended March 31, 2014 and 2013 and through March 31, 2015, there were no disagreements with Deloitte Haskins & Sells on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to Deloitte Haskins & Sells LLP's satisfaction, would have caused Deloitte Haskins & Sells to make reference to the subject matter thereof in connection with its reports for such years; or reportable events that would be required to be described under Item 16F(a)(1)(v) of Form 20-F in connection with the company's annual report on Form 20-F. Deloitte Haskins & Sells requested the Audit Committee retain independent external forensic investigators to conduct an investigation into the issues raised in a short seller report dated July 30, 2015 and other transactions identified by Deloitte Haskins & Sells in connection with its incomplete audit of the company's financial statements for the year ended March 31, 2015. Deloitte Haskins & Sells LLP also communicated to the Audit Committee that it would need to evaluate its responsibility under Section 10A of the U.S. Securities Exchange Act of 1934 if the Audit Committee were to fail to take timely and appropriate action in response to the matters identified above. Because Deloitte Haskins & Sells LLP was terminated prior to the Audit Committee commencing an investigation, Deloitte Haskins & Sells LLP has informed the company that it cannot determine: whether the Audit Committee took timely and appropriate action with respect to the matters identified above; whether the information obtained from an investigation would materially impact previously issued audit report or underlying financial statements for fiscal years ended March 31, 2014 and 2013; or whether the information obtained from an investigation would cause Deloitte Haskins & Sells to be unwilling to rely on management's representations. Accordingly, Deloitte Haskins & Sells has advised the company that it is not able to reissue its report or issue a consent to its inclusion in filings of the company with the SEC.
13:11 EDTYGECanadian Solar plummets after Q3 guidance, YieldCo comments
Subscribe for More Information
06:36 EDTYGEYingli Green Energy receives notice regarding NYSE continued listing standard
Subscribe for More Information
August 18, 2015
10:00 EDTANFIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:30 EDTANFIAmira Nature Foods downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
06:03 EDTQIWIVisa and QIWI implement contactless payment technology
Subscribe for More Information
05:37 EDTHIMXHimax to start shipping for HiSIT TDDI solution by Q4
Himax announced design-ins with key panel makers and OEMs for its best-in-class single-chip touch and display driver integration solution, HiSIT. In addition to the existing shipment of out-cell and on-cell solutions, Himax's "HiSIT" TDDI solution is ready for mass production and is expected to start shipping by the fourth quarter of 2015.
August 17, 2015
07:34 EDTNUANLeerink to hold a bus tour
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use